Suppr超能文献

T细胞免疫中的程序性死亡受体1(PD-1)及其配体

PD-1 and its ligands in T-cell immunity.

作者信息

Keir Mary E, Francisco Loise M, Sharpe Arlene H

机构信息

Department of Pathology, Harvard Medical School and Brigham and Women's Hospital, Boston, MA 02115, USA.

出版信息

Curr Opin Immunol. 2007 Jun;19(3):309-14. doi: 10.1016/j.coi.2007.04.012. Epub 2007 Apr 12.

Abstract

The past year has seen significant advances in our understanding of the critical roles of negative immunoregulatory signals delivered by the programmed death 1 (PD-1)-PD-1 ligand (PD-L) pathway in regulating T-cell activation and tolerance. Emerging evidence indicates that PD-Ls play an essential role on dendritic cells (DCs), both directly during DC-T cell interactions and indirectly through signaling into the DC. Recent studies point to a novel role for PD-L1 in maintaining tissue tolerance. Finally, PD-1 has recently been shown to be highly expressed on exhausted T cells during chronic viral infection, and blockade of PD-1 or PD-L1 can revive exhausted T cells, enabling them to proliferate and produce effector cytokines.

摘要

过去一年,我们对程序性死亡1(PD-1)-PD-1配体(PD-L)通路传递的负性免疫调节信号在调节T细胞活化和耐受中的关键作用有了重大进展。新出现的证据表明,PD-L在树突状细胞(DC)上起着至关重要的作用,无论是在DC与T细胞相互作用期间直接发挥作用,还是通过向DC发出信号间接发挥作用。最近的研究指出PD-L1在维持组织耐受方面有新作用。最后,最近研究表明,在慢性病毒感染期间,耗竭的T细胞上PD-1高度表达,阻断PD-1或PD-L1可使耗竭的T细胞恢复活力,使其能够增殖并产生效应细胞因子。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验